Cited by 299Colorectal Cancer Treatments and StudiesCancer Cells and MetastasisHepatocellular Carcinoma Treatment and Prognosis

Colorectal liver metastasis: molecular mechanism and interventional therapy

Open access
Zhou, Hui, Liu, Zhongtao, Wang, Yongxiang, Wen, Xiaoyong, Amador, Eric H., Yuan, Liqin, Ran, Xin, Xiong, Li +3 more·2022·Signal Transduction and Targeted Therapy

Abstract

Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a high morbidity additionally, CRC patients may develop liver metastasis, which is the major cause of death. Despite significant advances in diagnostic and therapeutic techniques, the survival rate of colorectal liver metastasis (CRLM) patients remains very low. CRLM, as a complex cascade reaction process involving multiple factors and procedures, has complex and diverse molecular mechanisms. In this review, we summarize the mechanisms/pathophysiology, diagnosis, treatment of CRLM. We also focus on an overview of the recent advances in understanding the molecular basis of CRLM with a special emphasis on tumor microenvironment and promise of newer targeted therapies for CRLM, further improving the prognosis of CRLM patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-022-00922-2

Cites

435 of 435 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Only 45% of colorectal cancer liver metastases can be resected with current methodology.

    “only 45% can be resected with current methodology.”

    From First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure (2024) · cites this paper as [43]

    The Introduction states that surgery is applicable in only 10–20% of colorectal liver metastasis cases, rather than 45%. The Surgery section discusses when resection is appropriate but gives no 45% figure. (LLM, conf=0.90)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Approximately 1 million patients are diagnosed worldwide with colorectal cancer liver metastases each year.

    “Of the approximately 1 million patients diagnosed worldwide with colorectal cancer liver metastases each year,43”

    From First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure (2024) · cites this paper as [43]

    The Introduction reports 1.9 million new colorectal cancer diagnoses worldwide in 2020, and the Epidemiology section says nearly 50% of patients develop liver metastases during the course of their disease (page numbers unavailable). Those figures suggest a number near one million, but the paper does not say that approximately one million patients are diagnosed with colorectal cancer liver metastases each year; lifetime development is not the same as annual diagnosis. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

7 retracted

Flagged first, then by citations

Research works printed but not linked: 3

  1. [303]Larsen, C. J. [Metastatic colonization of the liver by colorectal tumor cells is abolished by two micro-RNAs (miR-483-5p et miR-551a)]. Bull. Cancer102, 713–715 (2015). 26235418
  2. [321]Fang C Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis Cancer Med. 2017 6 2850 2857 29105339 PMC5727299
  3. [411]Ma L Zou X Chen W New A X-ray Induced Nanoparticle Photosensitizers For Cancer Treatment J. Biomed. Nanotechnol. 2014 10 1501 1508 25016650

Cited by

Sorted by citations

Authors
Zhou, H., Liu, Z., Wang, Y., Wen, X., Amador, E. H., Yuan, L., Ran, X., Xiong, L., Ran, Y., Chen, W., & Wen, Y.
Affiliations
  • Central South University (CN)
  • The University of Texas at Arlington (US)
  • Sichuan University (CN)
Corresponding author
  • Xiong, Li
  • Chen, Wei
  • Wen, Yu
Venue
Signal Transduction and Targeted Therapy
Published
2022-03-04
Volume
7
Issue
1
Pages
70-70
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4214924743
Cited by
298
References
435
Citations by year
2026: 55 · 2025: 99 · 2024: 68 · 2023: 60 · 2022: 16
FWCI
7.45
Type
journal article
Language
en
Open access
Locations
  • Signal Transduction and Targeted Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Anglia Ruskin Research Online (Anglia Ruskin University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • University of Texas at Arlington
  • National Natural Science Foundation of China (82000756, 81873640, 81970569, 81773293)
  • Hunan Provincial Science and Technology Department (2017WK2063, 2015GK3117)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
colorectal liver metastases, colorectal cancer, molecular mechanisms, tumor microenvironment, targeted therapy, diagnosis, treatment, prognosis
MeSH terms
Humans, Liver Neoplasms, Colorectal Neoplasms, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review